Past 10 year's financial track record analysis by Moneyworks4me indicates that SBI Life Insurance Company Ltd is a good quality company.
The key valuation ratios of SBI Life Insurance Company Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of SBI Life Insurance Company Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 22.9% | 20.2% | 19.2% | 20% | 19.9% | 17.3% | 16.3% | 14.5% | 14.5% | 14.1% | - |
| Value Creation Index ⓘ | 1.0 | 0.8 | 0.7 | 0.8 | 0.8 | 0.5 | 0.5 | 0.3 | 0.3 | NA | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales YoY Gr. | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - |
| Adj EPS ⓘ | 8.2 | 8.6 | 9.6 | 11.5 | 13.3 | 14.2 | 14.6 | 15.1 | 17.2 | 18.9 | 21.8 |
| YoY Gr. | - | 5% | 10.9% | 20.4% | 15.4% | 7.2% | 2.4% | 3.4% | 14.2% | 10% | - |
| BVPS (₹) ⓘ | 39.7 | 46.9 | 54.7 | 63.7 | 74.6 | 88.8 | 100.9 | 114.1 | 129.1 | 145.7 | 162.3 |
| Adj Net Profit ⓘ | 820 | 861 | 955 | 1,150 | 1,327 | 1,422 | 1,456 | 1,506 | 1,721 | 1,894 | 2,181 |
| Cash Flow from Ops. ⓘ | 2,715 | 5,778 | 8,525 | 10,395 | 13,473 | 19,299 | 23,878 | 21,852 | 28,656 | 29,122 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | NA | NA | ||||
| Adj EPS ⓘ | 9.7% | 7.3% | 9.1% | 10% | ||||
| BVPSⓘ | 15.5% | 14.3% | 13% | 12.8% | ||||
| Share Price | - | 9.8% | 7.9% | 4.3% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.6 | 13.8 | - |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21 |
Return on Equity has increased versus last 3 years average to 14.10%
Sales growth is good in last 4 quarters at 14.75%
Sales growth has been subdued in last 3 years 0.00%
Net Profit has been subdued in last 3 years 9.10%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 21.8 | - |
| TTM Sales (₹ Cr.) | 82,805 | - |
| BVPS (₹.) ⓘ | 162.3 | - |
| Reserves (₹ Cr.) ⓘ | 15,257 | - |
| P/BV ⓘ | 9.39 | - |
| PE ⓘ | 69.96 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 1307.00 / 1935.00 |
| All Time Low / High (₹) | 487.00 / 1935.00 |
| Market Cap (₹ Cr.) | 1,52,606 |
| Equity (₹ Cr.) | 1,002.1 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 21 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income From Investments | 276 | 318 | 402 | 452 | 506 | 477 | 688 | 983 | 795 | 1,034 |
| Other Income ⓘ | 7 | 8 | 8 | 11 | 14 | 7 | 6 | 5 | 1 | 0 |
| Expenses | 2 | 117 | 90 | 108 | 129 | 525 | 856 | 1139 | 1745 | 1679 |
| Profit Before Tax | 834 | 874 | 975 | 1,184 | 1,373 | 1,414 | 1,542 | 1,561 | 1,758 | 1,942 |
| Tax ⓘ | 14 | 13 | 20 | 34 | 46 | -9 | 87 | 55 | 38 | 48 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 820 | 861 | 955 | 1,150 | 1,327 | 1,422 | 1,456 | 1,506 | 1,721 | 1,894 |
| Adjusted EPS (₹) | 8.20 | 8.61 | 9.55 | 11.50 | 13.27 | 14.22 | 14.56 | 15.05 | 17.19 | 18.91 |
| Dividend Payout Ratio (%) | 15% | 17% | 16% | 17% | 15% | 0% | 17% | 13% | 15% | 14% |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Share Capital ⓘ | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,001 | 1,001 |
| Reserve and Surplus | 2,974 | 3,691 | 4,465 | 5,374 | 6,460 | 7,884 | 9,092 | 10,417 | 11,922 | 13,588 |
| Fair Value A/C | 65 | 42 | 87 | 153 | 116 | -141 | 308 | 204 | 93 | 317 |
| Borrowings ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Policy Holders Fund | 501 | 335 | 776 | 943 | 1,056 | -1,587 | 2,727 | 3,207 | 2,039 | 4,719 |
| Funds For Appropriations | 1 | 0 | 0 | 193 | 282 | 714 | 842 | 994 | 1,143 | 1,337 |
| Total Liabilities ⓘ | 72,211 | 80,725 | 99,225 | 1,18,156 | 1,42,998 | 1,62,558 | 2,22,592 | 2,68,207 | 3,09,587 | 3,92,783 |
Assets | ||||||||||
| Investment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Loans | 2 | 124 | 178 | 171 | 173 | 364 | 358 | 363 | 389 | 389 |
| Total Net block | 265 | 301 | 507 | 511 | 563 | 568 | 564 | 524 | 520 | 551 |
| Total Assets ⓘ | 72,211 | 80,725 | 99,225 | 1,18,156 | 1,42,998 | 1,62,558 | 2,22,592 | 2,68,207 | 3,09,587 | 3,92,783 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 2,715 | 5,778 | 8,525 | 10,395 | 13,473 | 19,299 | 23,878 | 21,852 | 28,656 | 29,122 |
| PBT ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjustment ⓘ | 3,314 | 7,352 | 9,450 | 11,384 | 14,871 | 20,891 | 25,556 | 23,836 | 30,846 | 31,558 |
| Changes in Working Capital ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Paid ⓘ | -600 | -1,574 | -924 | -989 | -1,398 | -1,593 | -1,678 | -1,984 | -2,190 | -2,437 |
| Cash Flow From Investing Activity ⓘ | -182 | -7,204 | -9,031 | -8,910 | -13,553 | -16,987 | -19,203 | -21,611 | -30,203 | -31,221 |
| Capex | -25 | -178 | -148 | -107 | -141 | -81 | -104 | -56 | -63 | -114 |
| Net Investments | -3,293 | -10,906 | -13,654 | -14,796 | -20,336 | -25,053 | -29,920 | -33,353 | -43,161 | -46,036 |
| Others ⓘ | 3,136 | 3,880 | 4,771 | 5,993 | 6,925 | 8,147 | 10,821 | 11,798 | 13,021 | 14,929 |
| Cash Flow From Financing Activityⓘ | -117 | -144 | -144 | -221 | -241 | -198 | 3 | -231 | -415 | -227 |
| Net Proceeds from Shares ⓘ | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 19 | 35 | 43 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Paid ⓘ | -100 | -120 | -120 | -150 | -200 | -200 | 0 | -250 | -450 | -270 |
| Others ⓘ | -17 | -24 | -24 | -71 | -41 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow ⓘ | 2,416 | -1,570 | -651 | 1,264 | -321 | 2,113 | 4,678 | 10 | -1,962 | -2,327 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | ||||||||||
| ROCE (%) | ||||||||||
| Asset Turnover Ratio | 0.19 | 0.2 | 0.23 | 0.23 | 0.25 | 0.26 | 0.26 | 0.24 | 0.23 | 0.23 |
| PAT to CFO Conversion(x) | 3.31 | 6.71 | 8.93 | 9.04 | 10.15 | 13.57 | 16.4 | 14.51 | 16.65 | 15.38 | Working Capital Days |
| Receivable Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SBI Life Insurance Company Limited (SBI Life), incorporated in the year 2000, established as joint venture between State Bank of India and BNP Paribas Cardif S.A. and is one of the leading life Insurance companies in India. SBI Life has a multi-channel distribution network comprising of an expansive Bancassurance channel with SBI, which has an unrivalled strength of many branches across the country. SBI Life also has a large and productive agent network. The Company’s other distribution channels include direct sales and sales through corporate agents, brokers, insurance marketing firms and other intermediaries. The Company is listed on National Stock Exchange (NSE) and The Bombay Stock Exchange (BSE).
Business area of the company
SBI Life offers a comprehensive range of life insurance and pension products at competitive prices, ensuring high standards of customer service and world class operating efficiency. The Company offers individual and group products which include savings and protection plans to address the insurance needs of diverse customer segments.
Products
SBI Life has a wide range of products catering to various customer needs in the life, health, pension & micro-insurance segments. These products are customer centric, simple to understand and have competitive features. The products include Individual Life Insurance Plans and Group Insurance Plans.
Awards
Milestones
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
